According to a recent World Health Organization estimate, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Background Dialysis and kidney transplant patients are vulnerable populations for COVID-
19 related disease and mortality. Methods We conducted a prospective study exploring the …

Importance Persons with immune dysfunction have a higher risk for severe COVID-19
outcomes. However, these patients were largely excluded from SARS-CoV-2 vaccine …

Background & Aims Two SARS-CoV-2 mRNA vaccines were approved to prevent COVID-19
infection, with reported vaccine efficacy of 95%. Liver transplant (LT) recipients are at risk of …

Objectives We aimed to evaluate the rates of antibody response to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine among kidney transplant recipients …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on
transplant recipients, with mortality rates up to 20%. Therefore, the effect of established …

Infection is a major cause of morbidity and mortality in patients with chronic kidney disease
(CKD), including those receiving maintenance dialysis or with a kidney transplant. Although …